Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Treatment for poststroke spasticity, the use of mydocalm

https://doi.org/10.14412/2074-2711-2011-170

Full Text:

Abstract

The paper gives the data available in the literature on the treatment of spasticity in poststroke patients. Therapeutic exercises that should be started just on the first days of stroke are noted to play a leading role in the treatment of poststroke spasticity. The local administration of botulinum toxin preparations (botox, dysport, xeomin) may be effective for managing local spasticity that deteriorates motor functions. Baclofen (baklosan), tizanidine (sirdalud), and tolperisone hydrochloride (mydocalm) may be used as oral medications. The paper also presents the results of a placebo-controlled trial that has indicated that mydocalm given in a dose of 300 to 900 mg/day may be effective in treating poststroke spasticity.

About the Author

V. A. Parfenov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Department of Nervous Diseases


For citation:


Parfenov V.A. Treatment for poststroke spasticity, the use of mydocalm. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(3):65-70. (In Russ.) https://doi.org/10.14412/2074-2711-2011-170

Views: 540


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)